Modeling Tumor Clonal Evolution for Drug Combinations Design
Cancer is a clonal evolutionary process. This presents challenges for effective therapeutic intervention, given the constant selective pressure toward drug resistance. Mathematical modeling from population genetics, evolutionary dynamics, and engineering perspectives are being increasingly employed...
Main Authors: | Zhao, Boyang, Hemann, Michael, Lauffenburger, Douglas A |
---|---|
Other Authors: | Massachusetts Institute of Technology. Computational and Systems Biology Program |
Format: | Article |
Published: |
Elsevier BV
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/116546 https://orcid.org/0000-0003-4610-1707 https://orcid.org/0000-0002-0050-989X |
Similar Items
-
An "AND" logic gate-based supramolecular therapeutic nanoplatform for combatting drug-resistant non-small cell lung cancer
by: Huang, Qili, et al.
Published: (2024) -
Genome instability is associated with ethnic differences between Asians and Europeans in hepatocellular carcinoma
by: Kaya, Neslihan Arife, et al.
Published: (2023) -
In vitro activity of fluconazole and voriconazole against
clinical isolates of Candida spp. by E-test method.
by: Jamal, Farida Fatema @ Farida, et al.
Published: (2010) -
Characterization of multiple drug-resistants pathogens isolated from clinical and environmental samples from nephrology unit of Hospital Serdang
by: Suntharamurthy, Seenu
Published: (2013) -
Design and characterization of inhibitory peptides against Bleg1_2478, B3 subclass Metallo-β-lactamase
by: Selvaraju, Gayathri
Published: (2021)